A patient with a progressive lower motor neuron syndrome had neurophysiological evidence of motor axon loss, multifocal proximal motor nerve conduction block, and high titres of anti-ganglioside GM1 antibodies. Neuropathological findings included a predominantly proximal motor radiculoneuropathy with multifocal IgG and IgM deposits on nerve fibres associated with a loss of spinal motor neurons. These findings support an autoimmune origin of this lower motor neuron syndrome with retrograde degeneration of spinal motor neurons and severe neurogenic muscular atrophy. (J Neurol Neurosurg Psychiatry 1993;56:982-987) 
Interest in the pathological role of anti-ganglioside antibodies has been stimulated by the identification of monoclonal IgM antibodies reacting with specific gangliosides in patients with motor neuron diseases and monoclonal gammopathy.l1 Polyclonal anti-GMl antibodies have also been found in the absence of a gammopathy in patients with motor neuron syndromes, particularly in a subgroup of patients with multiple motor neuropathy and lower motor neuron syndrome.5-9 The presence of these antibodies raises the possibility of an ongoing autoimmune process in patients with motor neuron disease. In a few of these patients improvement in strength has occurred after reduction of antibody titres by treatment with immunosuppressive drugs.5910 Anti-GM1 antibodies may bind to the nodes of Ranvier," but the significance of this antibody binding pattern and its role in nerve conduction block remain to be determined. 9 We report the clinical, immunological, physiological and pathological findings in a patient with lower motor neuron syndrome and a high titre of anti-ganglioside GM1 antibodies.
Methods

NEUROPHYSIOLOGY
Electrophysiological studies were performed using a Mystro system (Vickers Medical Corp). Multisegmental motor nerve conduction studies of both arms were performed with percutaneous supramaximal stimulation while recording the compound muscle action potential (CMAP) with TECA 4 mm surface disc electrodes and needle electrodes (radial nerve). Determination of conduction block and temporal dispersion included a more than 20% reduction in the negative CMAP amplitude and an increase in the negative duration of no more than 15% of the maximum CMAP elicited by stimulation at the proximal site compared with that evoked by distal stimulation.12 In cases where stimulation could not be applied proximally, a conduction block was admitted when the number of motor unit potentials evoked by graded stimulation was much greater than could be obtained during maximal voluntary contraction or when the total area of the CMAP was greater than the sum of the areas of the individual motor unit potentials."3 Motor nerve conduction studies were measured over long segments at conventional sites (Erb's point, axilla, elbow, wrist) and also over short segments for the ulnar nerve. F wave latencies from at least 10 responses were recorded following stimulation at the wrist. Using surface electrodes, sensory nerve action potentials were recorded orthodromically. Needle examination was performed using standard Dantec concentric electrodes.
ENZYME LINKED IMMUNOSORBENT ASSAY
The presence of anti-ganglioside GMl antibodies in serum was measured by the enzyme linked immunosorbent assay (ELISA) using a technique previously described. 8 The activity against other gangliosides GM2, GM3, GD1a, GDlb, asialo-GMl was also evaluated. The purified gangliosides were a kind gift of Dr A Martelli (Fidia Research Laboratories, Abano Terme, Italy). The weakness progressed in the arms and he was found to be tetraplegic in October 1988. In November 1989 he was found to have high anti-ganglioside GM1 antibodies and was reinvestigated. Examination revealed a severe hypotonic tetraplegia: in his arms and legs, only slight fingers and toes flexion could be seen. He also had weakness of the abdominal and respiratory muscles, but the cranial nerves remained normal. There was no sensory deficit or symptoms. Deep tendon reflexes were all absent, plantar responses were neutral, and no sphincter dysfunction or fasciculations were seen. On general examination diffuse oedema of the four limbs was noted.
Biochemical studies were within the normal range, including serum electrophoresis and immunoelectrophoresis, triiodothyronine, thyroxine thyroid stimulating hormone, and immunoelectrophoresis. Serological tests for syphilis, anti-DNA antibodies, CSF, and blood Lyme serology were normal or negative.
The patient was treated with chlorambucil, 9 mg daily but no improvement was observed over the next four months. Death occurred six years after onset. The necropsy was performed 48 hours after death.
Results
NEUROPHYSIOLOGY
The results of the nerve conduction studies are summarised in the table. There were motor conduction blocks in four nerves out of the eight tested on both sides, all of them located at the right Erb's point. The degree of the block was more than 50% for the radial and ulnar nerves. For the axillary and musculocutaneous nerves the number of motor unit potentials evoked by graded stimulation was greater than could be obtained during maximal voluntary contraction. The blocks were associated with a low distal amplitude of the CMAP, expressing axonal loss. Despite the low distal amplitude which leads to difficulty in measuring the block, the proximal and distal responses were of the same shape and could be superimposed: the difference in duration of CMAPs did not exceed 10% between distal and proximal responses. The differences in amplitude were thus not simply due to increased dispersion of CMAPs. The conduction velocity for the remaining nerve fibres was nearly normal or diminished by less ially showed no neuronal loss, neuronal inclusions, or gliosis. The corticospinal tract showed no axonal loss or demyelination or any other significant lesion at all the levels examined, including corona radiata, internal capsule, mesencephalic peduncle, pontine and bulbar portions, and along the spinal cord. Pure motor peripheral nerves were not examined, but the large mixed sensorimotor sciatic and peroneal nerves showed severe pathological changes clearly affecting some fascicles more than others (fig 3) . There was severe axon depletion with loss of myelin and a reactive proliferation of Schwann cells and fibrosis. Immunohistochemistry performed on unfixed frozen samples of the same nerves showed multifocal deposits of IgM (fig 4) and IgG, but not IgA, in relatively well preserved fascicles on the nerve fibres.
Discussion
The slow progression, lack of brisk reflexes, and absence of bulbar dysfunction were clinical features that helped to distinguish our case from amyotrophic lateral sclerosis. Antibodies to ganglioside GM1 are not usually found in patients with presumably nonimmune lower motor neuron syndromes such as spinal muscular atrophy.7-9 High titres of serum anti-ganglioside GM1 antibodies (>4 SD above the mean value), are found in some motor neuron disease and peripheral motor neuropathy, whereas low titres (<100 in our laboratory) are less specific and may be found in sera from patients with a variety of neurological and autoimmune disorders.89 Two motor syndromes may be considered in our patient: a multifocal motor neuropathy and a lower motor neuron syndrome.9 These syndromes may overlap with similar clinical and immunological features, but in lower motor neuron syndrome no motor conduction block may be seen on physiological studies,9 and these patients may develop widespread weakness and atrophy suggestive of a spinal muscular atrophy and a progressive course leading to death.
Recent papers have underscored that a drop in the recorded CMAP amplitude from proximal to distal stimulation is insufficient to recognise conduction block and alternative interpretations should be considered. 13 In our patient, we did not find abnormal desynchronisation that could result in a reduction of the CMAP. Insufficient stimulus intensity is unlikely because we stimulated Erb's point with different stimulators and differing the position of the patient without modifying the amplitude of the evoked responses. The interpretation of these findings is difficult when the usual physiological consequences of demyelination, such as slight conduction delay and prolonged F responses, are absent.'2 We postulate that the proximal conduction blocks in our patient could be due to the severity of the axonal loss with an increased excitation threshold in the remaining motor nerve fibres. The onset of the disease in the legs and the severity of the axonal loss, with "axonal" proximal conduction blocks on physiological studies make the diagnosis of lower motor neuron syndrome more likely than multifocal motor neuropathy.
Conditions involving a primary motor neuropathy with secondary degeneration of motor neurons or a primary motor neuron disorder with secondary axonal degeneration have to be considered in the light of the pathological study. We found a predominantly motor, proximally accentuated, radiculoneuropathy with multifocal IgG and IgM deposits on the nerve fibres and a slowly ascending retrograde degeneration of the spinal motor neurons with a corresponding severe, partly endstage neurogenic muscular atrophy.
A primary spinal motor neuron disease seems to be unlikely in our case, since the severity of the observed changes were more accentuated in the anterior roots, followed by the peripheral nerves and finally by the changes in the anterior horn cells. 15 and further investigations of the role of anti-GM1 antibodies in peripheral nerve are needed to elucidate the exact structure to which they react.
High anti-gangliosides GM1 titres have been shown to be relatively specific for patients with lower motor neuron disease,' 3 6 9 16 motor neuropathies,567896 or, more rarely, sensorimotor neuropathy.7'6 Gangliosides are important components of nerve membrane in the peripheral and central nervous system, concentrated at the nodes of Ranvier'7 and at synaptic terminals.'8 It is interesting to note that TgM deposits have been localised to the nodes of Ranvier in a patient presenting with anti-GM1 antibodies and multifocal motor conduction block." It is, however, not clear under which conditions the antibodies gain access to their targets and why there is a selective vulnerability of motor nerves.9 The antigen might be more concentrated or more accessible in motor nerves than in sensory nerves: a recent study of gangliosides GM1 in peripheral nerves suggested that there were different lengths of hydrophobic moieties of gangliosides GM1 between motor and sensory axons.'9 Further evidence of interaction with the motor system was provided by the demonstration that anti-gangliosides GM1 antibodies bind to nerve terminals.20 In our case, deposits of IgM could be demonstrated in peripheral nerves, but not on the surface of motor neurons, as has been previously demonstrated." These findings additionally favour the probable autoimmune origin of this lower motor neuron syndrome with secondary neurogenic muscle atrophy and retrograde degeneration of spinal motor neurons. Further pathological studies are necessary in patients with lower motor neuron syndromes with high titre of anti-gangliosides GM1 antibodies to confirm our findings and to further identify the targets and role of anti-GM1 antibodies.
